Lamba Deepak A, Gust Juliane, Reh Thomas A
Department of Biological Structure, University of Washington, Seattle, WA 98195, USA.
Cell Stem Cell. 2009 Jan 9;4(1):73-9. doi: 10.1016/j.stem.2008.10.015.
Some of the most common causes of blindness involve the degeneration of photoreceptors in the neural retina; photoreceptor replacement therapy might restore some vision in these individuals. Embryonic stem cells (ESCs) could, in principle, provide a source of photoreceptors to repair the retina. We have previously shown that retinal progenitors can be efficiently derived from human ESCs. We now show that retinal cells derived from human ESCs will migrate into mouse retinas following intraocular injection, settle into the appropriate layers, and express markers for differentiated cells, including both rod and cone photoreceptor cells. After transplantation of the cells into the subretinal space of adult Crx(-/-) mice (a model of Leber's Congenital Amaurosis), the hESC-derived retinal cells differentiate into functional photoreceptors and restore light responses to the animals. These results demonstrate that hESCs can, in principle, be used for photoreceptor replacement therapies.
一些导致失明的最常见原因涉及神经视网膜中光感受器的退化;光感受器替代疗法可能会恢复这些个体的部分视力。从理论上讲,胚胎干细胞(ESC)可以提供光感受器来修复视网膜。我们之前已经表明,视网膜祖细胞可以有效地从人类ESC中获得。我们现在表明,源自人类ESC的视网膜细胞在眼内注射后会迁移到小鼠视网膜中,定居到适当的层,并表达分化细胞的标志物,包括视杆和视锥光感受器细胞。将这些细胞移植到成年Crx(-/-)小鼠(莱伯先天性黑蒙症模型)的视网膜下间隙后,源自人胚胎干细胞的视网膜细胞分化为功能性光感受器,并恢复动物的光反应。这些结果表明,从理论上讲,人胚胎干细胞可用于光感受器替代疗法。